|
Volumn 15, Issue 2, 2001, Pages 311-312
|
Autologous peripheral blood stem cell transplantation for adult patients with B-cell lymphoma-associated hemophagocytic syndrome
a a a a a a b c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BUSULFAN;
C REACTIVE PROTEIN;
CARBOPLATIN;
CD34 ANTIGEN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
FERRITIN;
HLA ANTIGEN;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR;
LACTATE DEHYDROGENASE;
MEPREDNISONE;
MYELOABLATIVE AGENT;
PREDNISONE;
RANIMUSTINE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
VINCRISTINE;
ADULT;
AUTOTRANSPLANTATION;
B CELL LYMPHOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER SURVIVAL;
CELL SORTER;
CLINICAL ARTICLE;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE ASSOCIATION;
DOSE RESPONSE;
DRUG MEGADOSE;
FEMALE;
FLOW CYTOMETRY;
GRAFT REJECTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMOPHAGOCYTIC SYNDROME;
HUMAN;
HUMAN CELL;
JAPAN;
LETTER;
LEUKOCYTE COUNT;
MALE;
PERIPHERAL BLOOD STEM CELL;
PRIORITY JOURNAL;
PROGNOSIS;
PYREXIA IDIOPATHICA;
STOMATITIS;
TREATMENT OUTCOME;
TREATMENT PLANNING;
UNIVERSITY HOSPITAL;
|
EID: 0035109339
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2402030 Document Type: Letter |
Times cited : (11)
|
References (8)
|